Cellular Biomedicine

Cellular Biomedicine is a company listed under the stock ticker CBMG (US).

View the org chart displaying its 14 main executives

Most searched biographies at Cellular Biomedicine

• Tony Liu, Executive Director, Chief Executive Officer and Chief Fi...
• Darren O'Brien, Director
• Alan Au, Independent Director

Create your alert
to follow the executive moves at Cellular Biomedicine.

Cellular Biomedicine has 2,275 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Bruker has announced the acquisition of NanoString Technologies  (posted on April 18 2024).
• Vertex Pharmaceuticals has announced the acquisition of Alpine Immune Sciences  (posted on April 16 2024).
• Nurix Therapeutics has just announced a $175 Million fundraising (posted on April 13 2024).

Popular contacts in Biotechnology

• Vik Bajaj - Director at Interline Therapeutics
• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Cellular Biomedicine

• CBMG Announces Exclusive Collaboration and License Agreement with Janssen to Develop and Commercialize anti CD19 & CD20 Bi-Specific and anti CD20 CAR-Ts for Non-Hodgkin Lymphoma
• CBMG Announces FDA Clearance of IND Application for Novel TIL Therapy C-TIL051
• industry_news

Social media about Cellular Biomedicine

• Cellular Biomedicine on Wikipedia, Google News & Yahoo Finance
• Cellular Biomedicine on LinkedIn, Twitter & YouTube

Contact by email its executives including Tony Liu

Call Cellular Biomedicine at +1 650...

View the org chart

Register to receive your alert

Report an error